News - Pharmaceutical
Teva Pharmaceutical: A Company In Transition
31 December 2013
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha).
Click on the link to read the full article at Seeking Alpha (This link will open in a new window)US FDA grants ANDA for Breckenridge's rizatriptan benzoate tablets
31 December 2013
Established in 1983, Breckenridge is a private pharmaceutical marketing, research and development company that markets number of generic prescription products and medical foods for wide therapeutic categories. Share: Delicious · Digg · submit to reddit ...
Click on the link to read the full article at Pharmaceutical Business Review (This link will open in a new window)Biotech & Pharmaceutical Patenting 2013
29 December 2012
IBC Legal will be holding its 21st annual Biotech & Pharmaceutical Patenting conference on February 26-27, 2013 in Munich, Germany. Conference highlights include: ? Benefit from the latest trends in patent protection strategies and competitive patent ...
Click on the link to read the full article at Patent Docs (This link will open in a new window)Pharmaceutical firm caught in kickback scheme
29 December 2012
27, San Diego pharmaceutical company Victory Pharma Inc. agreed to pay $11.4 million to settle Anti-Kickback Statute and False Claims Act allegations. The deferred prosecution agreement resolves allegations that Victory promoted its drugs by paying ...
Click on the link to read the full article at Examiner.com (This link will open in a new window)K-V Pharmaceutical Receives Court Approval of Hologic Settlement
28 December 2012
28, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the Company") today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement ...
Click on the link to read the full article at PR Newswire (press release) (This link will open in a new window)Catalonia's pharmaceutical spending dropped by 23.9% in November compared ...
28 December 2012
Madrid (ACN).- Pharmaceutical expenditure dropped in Catalonia by 23.9% in November compared to the same month in 2011, according to data released on Thursday by the Spanish Ministry of Health, Social Services and Equality. Pharmaceutical turnover ...
Click on the link to read the full article at Catalan News Agency (This link will open in a new window)Pharmaceutical veteran backs govt's move
28 December 2012
A former top executive at Sanofi-Aventis believes that separating the roles of private physicians and pharmacists is justified. PETALING JAYA: Malaysia is moving in the right direction if the Health Ministry decides to separate the functions of doctors ...
Click on the link to read the full article at Free Malaysia Today (This link will open in a new window)US FDA approves Aurobindo Pharma's nafcillin injections
28 December 2012
Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients for six areas, which include antibiotics, anti-retrovirals, CVS, CNS, gastroenterologicals and anti-allergics. Share: Delicious · Digg · submit to reddit ...
Click on the link to read the full article at Pharmaceutical Business Review (This link will open in a new window)FDA Approvals of NMEs and BLAs Increased in 2012
27 December 2012
December is typically an active month for FDA approvals, and December 2012 was no exception. For December 2012 (as of Dec. 24, 2012), FDA's CDER approved five new drugs. Ariad Pharmaceuticals received approval for Iclusig (ponatinib) for treating ...
Click on the link to read the full article at Pharmaceutical Technology Magazine (blog) (This link will open in a new window)Highs & Lows: Teva Pharmaceutical, Best Buy, and Tellabs
27 December 2012
Today's resumed budget talks are ramping up investor anxiety, as U.S. indices are sagging considerably in the red. A mixed bag of economic data -- including a drop in first-time jobless claims and a dip in consumer confidence -- hasn't helped to draw ...
Click on the link to read the full article at Schaeffers Research (blog) (This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
